GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » MediPharm Labs Corp (TSX:LABS) » Definitions » Price-to-Funds-From-Operations

MediPharm Labs (TSX:LABS) Price-to-Funds-From-Operations : (As of Jun. 02, 2024)


View and export this data going back to 2018. Start your Free Trial

What is MediPharm Labs Price-to-Funds-From-Operations?

Price-to-Funds-From-Operations only applies to REITs.


MediPharm Labs (TSX:LABS) Business Description

Traded in Other Exchanges
Address
151 John Street, Barrie, ON, CAN, L4N 2L1
MediPharm Labs Corp is a pharmaceutical company specializing in precision-based cannabinoids. The Company operates in one reportable segment, the production and sales of cannabis extracts and derivative products. Through its wholesale and white-label platforms, MediPharm Labs formulates, develops, processes, packages, and distributes cannabis extracts and cannabinoid-based products to domestic and international markets. Geographically company has a presence in Canada, Australia, Germany, and other countries and the majority of revenue derives from Canada.
Executives
Keith Strachan Director